Glypican-3-Specific CAR NK Cells Co-Secreting IL-15 and IFN-α Have Increased Anti-Tumor Function Versus Hepatocellular Carcinoma In Vitro
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262411892 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Rosalia Busà und 9 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS ISMETT, 90127 Palermo, Italy. Hauptthemen laut MEDLINE: Interleukin-15, Carcinoma, Hepatocellular, Glypicans, Liver Neoplasms. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Ri.MED (Fondo Generale, ID 10019) and IRCCS-ISMETT ATMP-P A105412 project, The Italian Ministry of Health, Fondazione Ri.MED.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR)-modified natural killer (NK) cells represent a promising immunotherapeutic approach for the treatment of oncological malignancies such as hepatocellular carcinoma (HCC). In this work, we have engineered primary human NK cells, re-directing them so they can specifically recognize Glypican-3 (GPC3), an immunotherapeutic target for HCC. In previous studies, we have demonstrated that IFN-α significantly enhances NK cells’ anti-tumor and anti-viral cytotoxicity. Fourth-generation self-inactivating lentiviral vectors were used to deliver a transgenic expression of IFN-α or its co-expression with IL-15 (which induces NK cells expansion, survival, and function), aiming to enhance CAR-GPC3 NK cells’ anti-tumor response against HCC. We optimized a protocol for efficient transduction of primary NK cells, demonstrating that CAR expression is maintained at high levels over time. Exposure of HCC ectopically expressing GPC3+ to CAR-GPC3-IL15 and CAR-GPC3-IL15-IFNα NK cells demonstrated significant in vitro cytotoxicity and cytokine production, dependent on GPC3 expression. To prevent undesired side effects of CAR-NK cell immunotherapy, co-delivery with a suicide gene is advised as a safety measure. Thus, a truncated epidermal growth factor receptor (tEGFR) was co-delivered with the anti-GPC3 CAR, which efficiently promoted the suicide of the CAR-NK used in this work. Our study demonstrates the efficacy of re-directed CAR-GPC3 primary NK cells, encouraging further preclinical and clinical translation studies and strengthening the potential of these cells as a novel treatment option for patients with HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS ISMETT, 90127 Palermo, Italy.
- Department of Medicine and Surgery, Kore University of Enna, 94100 Enna, Italy.
- Fondazione Ri.MED, 90133 Palermo, Italy.
- Department of Surgery and Medical and Surgical Specialties, University of Catania, 95124 Catania, Italy.
ORCID-Profile: Rosalia Busà, Gioacchin Iannolo, Bruno Douradinha, Duilio Pagano, Salvatore Gruttadauria, Pier Giulio Conaldi, Ester Badami
Förderung
- Fondazione Ri.MED (Fondo Generale, ID 10019) and IRCCS-ISMETT ATMP-P A105412 project
- The Italian Ministry of Health
- Fondazione Ri.MED
- ISMETT
- Italian Ministry of Health, Ricerca Corrente
Zitieren
APA
Busà, R., Iannolo, G., Douradinha, B., Pagano, D., Gallina, A., Cappello, G., La Rocca, A., Gruttadauria, S., Conaldi, P. G., & Badami, E. (2025). Glypican-3-Specific CAR NK Cells Co-Secreting IL-15 and IFN-α Have Increased Anti-Tumor Function Versus Hepatocellular Carcinoma In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411892
Vancouver
Busà R, Iannolo G, Douradinha B, Pagano D, Gallina A, Cappello G, et al. Glypican-3-Specific CAR NK Cells Co-Secreting IL-15 and IFN-α Have Increased Anti-Tumor Function Versus Hepatocellular Carcinoma In Vitro. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411892
BibTeX
@article{Bus2025,
author = {Busà, Rosalia and Iannolo, Gioacchin and Douradinha, Bruno and Pagano, Duilio and Gallina, Anna and Cappello, Giancarlo and La Rocca, Antonio and Gruttadauria, Salvatore and Conaldi, Pier Giulio and Badami, Ester},
title = {Glypican-3-Specific CAR NK Cells Co-Secreting IL-15 and IFN-α Have Increased Anti-Tumor Function Versus Hepatocellular Carcinoma In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262411892}
}
EUVIMED